🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The NCPE is recruiting! We are expanding our team to build capacity for significant EU and national developments in HTA! If you would be interested in applying for a HTA assessor or statistician role, further information can be found at: stjamescareers.ie/Home/Job?chkCa…

Dr David McConnell presents on research relating to the incorporation of external information to survival extrapolations - a novel approach for addressing uncertainty in HTA!

Our head of strategy, Dr Roisin Adams, is talking now at the opening plenary this morning at HTAi #htai2024

Heather Eames presented on how semi automated horizon scanning can complement national horizon scanning processes. This research was made possible by the NCPE’s membership in the international horizon scanning initiative. More info on IHSI is available at: ihsi-health.org

We are accepting applications until this Sunday the 30th of June!

The NCPE are seeking input from Patient Organisations for our appraisal of anifrolumab (Saphnelo®) as an add-on for adult patients with moderate/severe, active autoantibody-positive systemic lupus erythematosus, despite standard therapy. More details at (ncpe.ie/for-patients)

The NCPE are seeking input from Patient Organisations for our appraisal of tezepelumab (Tezspire®) as add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma, who are inadequately controlled despite high-dose inhaled corticosteroids (1/2)

Great to see that research led by Shikha Sharma (NCPE and HEALED consortium) “Systematic review of economic evaluations of systemic treatments for second or later line treatment for advanced and metastatic gastric cancer” published (doi.org/10.1007/s40273…) (1/2)

Well done Shikha Sharma for leading this useful reaserch for #HEALED. #ThisIsTrinityMed

The NCPE are seeking input from Patient Organisations for our appraisal of zanubrutinib (Brukinsa) monotherapy for adult patients with relapsed/refractory marginal zone lymphoma with at least one prior anti-CD20-based therapy. More details at  (ncpe.ie/for-patients)

🔔 Our Annual Symposium Schedule has been finalised! 🔔 The NCPE Annual Symposium will be held on Thursday 10th October 2024 in Dublin Castle. Registration is available at ncpe.ie/save-the-date-…

The NCPE is hiring! Would you be interested in applying for the role of Health Technology Assessor at the NCPE? The NCPE is building capacity to develop our national assessment work, European HTA collaborations and national HTA policy. Apply at: stjamescareers.ie/Job/JobDetail?…

The NCPE are seeking input from Patient Organisations for our appraisal of Ivosidenib (Tibsovo), for patients with newly diagnosed acute myeloid leukaemia, with an IDH1 R132 mutation, who are not eligible to receive standard induction chemotherapy. See: ncpe.ie/for-patients)

Would you be interested in applying for the role of Health Technology Assessor or Senior Health Technology Assessor at the NCPE? We are accepting applications until the 28th of October at ncpe.ie/vacancies-at-t…

🌟We are still accepting applications for three health technology assessors and a senior health technology assessor until October 28th! 🌟

Laura McCullagh Lea Roisin Adams @cathalwalsh.bsky.social

An exciting opportunity to work within a collaboration of experts NCPE National Cancer Registry Ireland TILDA and international experts. #ThisIsTrinityMed

‼️ We are moving to LinkedIn ‼️ You can find our LinkedIn account at linkedin.com/company/ncpe-n…

Three School of Medicine researchers have been awarded HealthResearchBoard grants through the new Evidence for Policy Programme for patient-oriented research projects. Congratulations to Sara Burke, Irina Kinchin and Laura McCullagh! 👏🏻 More:tcd.ie/news_events/ar… #TrinityResearch